Ortin Global Share Price | Ortin Global Stock Screener
ORTINGLOBE
Pharmaceuticals
Share Price NSE
₹15.41
▼
-0.90 (-5.52%)
Share Price BSE
₹13.75
▼
-0.65 (-4.51%)
As of December 9, 2025, the Ortin Global share price (NSE: ORTINGLOBE) is ₹15.41 on NSE and ₹13.75 on BSE, down 5.52% from the previous close, with shares trading between ₹15.22 and ₹17.46, and a 52-week range of ₹11.19–₹16.31.
Check ORTINGLOBE annual price range for the annual price range and momentum.
Use the Ortin Global stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Ortin Global Market Cap
₹11.83 Cr.
ORTINGLOBE P/E Ratio (TTM)
-13.27
Ortin Global P/B Ratio
9.14
EPS (TTM)
₹-1.04
Dividend Yield
-
Debt to Equity
0.43
ORTINGLOBE 52 Week High
₹16.31
Ortin Global 52 Week Low
₹11.19
Operating Margin
-5.00%
Profit Margin
-
ORTINGLOBE Revenue (TTM)
₹13.00
EBITDA
₹-1.00
Net Income
-
Total Assets
₹4.00
Total Equity
₹2.00
Ortin Global Share Price Chart
Screen Ortin Global share price with an interactive chart. Analyse ORTINGLOBE price trends and volatility across different timeframes.
Ortin Global Company Profile - Fundamental Screener
Screen Ortin Global company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ORTINGLOBE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE749B01020
Ortin Global Balance Sheet Screener
Screen ORTINGLOBE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 4 | 7 | 21 | 21 | 21 | 117 | 105 | 74 | 62 | 65 |
| Current Assets | 3 | 6 | 7 | 6 | 6 | 92 | 82 | 52 | 38 | 31 |
| Fixed Assets | 0 | 0 | 14 | 14 | 14 | 23 | 21 | 20 | 21 | 22 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 2 | 3 | 2 | 2 | 9 | 8 | 8 | 8 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2 | 3 | 11 | 11 | 11 | 24 | 25 | 24 | 23 | 23 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | -6 | -5 | 3 | 3 | 3 | 7 | 8 | 7 | 7 | 6 |
Ortin Global Income Statement Screener - Profit & Revenue Analysis
Screen Ortin Global income statement and profit fundamentals.
Analyze ORTINGLOBE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Ortin Global share price evaluation.
| Item | 2012-Jun | 2012-Mar |
|---|---|---|
| Revenue | 13 | 18 |
| Expenses | 14 | 21 |
| EBITDA | -1 | -3 |
| Operating Profit % | -5.00% | -19.00% |
| Depreciation | 0 | 0 |
| Interest | 1 | 1 |
| Profit Before Tax | 1 | -2 |
| Tax | 0 | 0 |
| Net Profit | 0 | -2 |
| EPS | 0.26 | -1.13 |
Ortin Global Cash Flow Screener - Liquidity Fundamentals
Screen ORTINGLOBE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -5 | 0 | 2 | 18 | 3 | 7 | 2 | 2 | 1 |
| Investing Activities | 0 | 12 | 0 | 0 | 0 | -3 | -3 | -1 | -1 | -1 |
| Financing Activities | 0 | -4 | 1 | -1 | -10 | -1 | -3 | 0 | -1 | 0 |
| Net Cash Flow | 0 | 4 | 1 | 2 | 8 | -1 | 0 | 1 | 0 | 0 |
Ortin Global Shareholding Pattern Screener
See Ortin Global shareholding pattern with promoter, FII, and DII holdings.
Check Ortin Global promoter holding and ownership changes for ORTINGLOBE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% |
| FII Holding | 1.68% | 6.53% | 6.53% | 1.68% | 1.68% | 0.00% | 6.25% | 6.25% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 91.18% | 85.32% | 85.66% | 90.85% | 91.01% | 92.04% | 85.84% | 83.55% |
| Other Holding | 5.90% | 6.92% | 6.58% | 6.23% | 6.08% | 6.73% | 6.68% | 8.97% |
| Shareholder Count | 11,452 | 12,144 | 12,034 | 12,060 | 11,834 | 12,192 | 11,952 | 12,165 |
Ortin Global Share Dividend Screener - Share Yield Analysis
Check Ortin Global dividend history with payout and yield data.
View Ortin Global dividend details including ex-dates and amounts for ORTINGLOBE stock.
Ortin Global Stock Index Membership
See which indices include Ortin Global stock.
Check ORTINGLOBE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Ortin Global Market Events Screener - Corporate Actions
Get Ortin Global corporate actions including splits, bonuses, and buybacks.
Check Ortin Global stock events that may affect ORTINGLOBE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -13.38% | ||
| Annual General Meeting | NA | -7.76% | ||
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 28.83% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 2.63% |
| 2025-08-25 | 2025-08-25 | Extraordinary General Meeting | NA | -12.27% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -22.42% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 1.86% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.51% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.40% |
| 2024-04-11 | 2024-04-11 | Extraordinary General Meeting | NA | 2.58% |
| 2024-04-05 | 2024-04-05 | Extraordinary General Meeting | NA | -3.35% |
| 2024-02-13 | 2024-02-13 | Change Of Name | NA | 0.00% |
| 2023-12-14 | 2023-12-14 | Extraordinary General Meeting | NA | 3.99% |
Ortin Global Competitors Screener - Peer Comparison
Screen ORTINGLOBE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Ortin Global Company Announcements - News Screener
Screen ORTINGLOBE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-10 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-30 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-11 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-02-27 | Corrigendum to Detailed Public Statement | - |
| 2026-02-26 | Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-26 | Draft Letter of Offer | - |
| 2026-02-18 | Detailed Public Statement | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14.02.2026 | - |
| 2026-02-14 | Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025 | - |
| 2026-02-14 | Corrigendum to the Public Announcement | - |
| 2026-02-11 | Public Announcement - Open Offer | - |
| 2026-02-05 | Board Meeting Intimation for Meeting To Be Held On 14.02.2026 | - |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-26 | Closure of Trading Window | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2025 | - |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 | - |
| 2025-11-07 | Board Meeting Intimation for Meeting To Be Held On 14.11.2025 | - |